Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells ; volume:3 ; number:1 ; day:28 ; month:1 ; year:2005 ; pages:1-10 ; date:12.2005
Journal of translational medicine ; 3, Heft 1 (28.1.2005), 1-10, 12.2005
- Creator
-
Akiyama, Yasuto
- Contributor
-
Tanosaki, Ryuji
Inoue, Naoki
Shimada, Makiko
Hotate, Yukie
Yamamoto, Akifumi
Yamazaki, Naoya
Kawashima, Ichirō
Nukaya, Ikuei
Takesako, Kazutoh
Maruyama, Kouji
Takaue, Yoichi
Yamaguchi, Ken
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-3-4
- URN
-
urn:nbn:de:1111-2016041430683
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Akiyama, Yasuto
- Tanosaki, Ryuji
- Inoue, Naoki
- Shimada, Makiko
- Hotate, Yukie
- Yamamoto, Akifumi
- Yamazaki, Naoya
- Kawashima, Ichirō
- Nukaya, Ikuei
- Takesako, Kazutoh
- Maruyama, Kouji
- Takaue, Yoichi
- Yamaguchi, Ken
- SpringerLink (Online service)
Other Objects (12)
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma
METASTATIC MALIGNANT MELANOMA OF SKIN
Novel treatment paradigms for metastatic uveal melanoma
Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma
Gastric Metastatic Melanoma Mimicking a Hyperplastic Lesion
Gastrointestinal Metastatic Melanoma: The Key for Diagnosis
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial
Improved dendritic cell vaccination for combined melanoma immune therapy
Improved dendritic cell vaccination for combined melanoma immune therapy
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma
METASTATIC MALIGNANT MELANOMA OF SKIN
Novel treatment paradigms for metastatic uveal melanoma
Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma
Gastric Metastatic Melanoma Mimicking a Hyperplastic Lesion
Gastrointestinal Metastatic Melanoma: The Key for Diagnosis
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial
Improved dendritic cell vaccination for combined melanoma immune therapy
Improved dendritic cell vaccination for combined melanoma immune therapy
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma
METASTATIC MALIGNANT MELANOMA OF SKIN
Novel treatment paradigms for metastatic uveal melanoma
Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma
Gastric Metastatic Melanoma Mimicking a Hyperplastic Lesion
Gastrointestinal Metastatic Melanoma: The Key for Diagnosis
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial
Improved dendritic cell vaccination for combined melanoma immune therapy